Recombinant SARS-CoV-2 fusion protein vaccine

· Livzon Pharmaceutical Group Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant SARS-CoV-2 fusion protein vaccine, covering 2022-03-29 to 2022-03-29. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein Vaccine [Phase 2]